Shanghai Universal Biotech Co (301166.SZ) Stock Price

Shanghai Universal Biotech Co Price

CLOSED
31.10
​
Market closed

Revenue has compounded at 21.1% per year over the past 12 years to 1.08 B CNY. Earnings per share have declined at 8.9% per year over the last 11 years. Shanghai Universal Biotech Co's net margin stands at -2.1%, down from 9.8% several years earlier. Shanghai Universal Biotech Co currently offers a dividend yield of about 0.74%.

Shanghai Universal Biotech Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shanghai Universal Biotech Co business model & stock analysis

Shanghai Universal Biotech Co Ltd provides life science research services, life science instruments, consumables, and technical services. The company is headquartered in Shanghai, China, with 688 employees. It completed its IPO on December 28, 2021. Its products include third-party brand life science reagents such as immunological, molecular biology, cell biology, and biochemical reagents, alongside independent brand products. Instruments and consumables cover detection, analysis, and sample preparation. Technical services encompass experimental and support services.

Frequently asked questions about Shanghai Universal Biotech Co

5 analysts currently rate the Shanghai Universal Biotech Co stock: 4 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Shanghai Universal Biotech Co share trades at 4.14 EUR (31.10 CNY).

The revenue cannot currently be calculated for Shanghai Universal Biotech Co.

The profit cannot currently be calculated for Shanghai Universal Biotech Co.

The P/E ratio cannot be calculated for Shanghai Universal Biotech Co at the moment.

The P/S cannot be calculated for Shanghai Universal Biotech Co currently.

The Eulerpool Quality Score for Shanghai Universal Biotech Co is 1/10.

The ISIN of Shanghai Universal Biotech Co is CNE100005709. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Shanghai Universal Biotech Co is 301166.SZ. The ticker symbol is used to trade Shanghai Universal Biotech Co shares on the stock exchange.

Fair ValueTerminal
30.17 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
1.58 M CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website univ-bio.com
Country
Currency
CNY
Initial public offering
Dec 28, 2021
ISIN
CNE100005709
Cusip
Y7693K105
Market capitalization
2.70 B CNYMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
1.34
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-1.14 %
Dividend
Dividend yield
0.74 %
Payout Ratio
-86.86 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
4 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
10.00 %
Last updated Oct 16, 2026, 6:37 PM

Shanghai Universal Biotech Co Peer Group

Shanghai Universal Biotech Co FIGI

301166:CH · BBG00WC0F0X2301166:CS · BBG00WC0F0Z0